{"title":"The tip of the iceberg: Morbidity in polycystic ovary syndrome in reproductive-age women","authors":"Blandine Courbiere, Eugénie Micolon, Appoline Zimmermann, Pascal Auquier, Julie Berbis, Sandrine Loubière","doi":"10.1016/j.ando.2026.102598","DOIUrl":null,"url":null,"abstract":"<div><h3>Context</h3><div>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, but its true burden remains underestimated due to diagnostic variability and underreporting.</div></div><div><h3>Objective</h3><div>To estimate the morbidities in reproductive-age women identified with a diagnosis of PCOS in the French national health data system.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study using the French national health data system (SNDS) to identify reproductive-age women (18–43 years) diagnosed with PCOS (ICD-10 code E28.2) between 2014 and 2022. Morbidity data were assessed in 2022 and compared with an age-matched control group of women without PCOS in the same year. Specific comorbidities were identified using a set of algorithms applied to the system's data and based on both ICD-10 codes and medical acts and drug use. Logistic regression models were used to compare comorbidity rates, with odds ratios adjusted for age and social deprivation.</div></div><div><h3>Results</h3><div>We identified 21,144 women with PCOS in the health data system. Median age was 35 years [IQR: 29–39]. Compared with the general female population, women with PCOS had significantly higher rates of infertility (adjusted odds ratio (aOR)<!--> <!-->=<!--> <!-->24.35), gestational diabetes (aOR<!--> <!-->=<!--> <!-->1.64), type 2 diabetes (aOR 14.71), pulmonary embolism (aOR<!--> <!-->=<!--> <!-->2.04), arterial hypertension (aOR 5.86), acute stroke (aOR= 2.39), cardioneurovascular disease (aOR 2.12) and psychiatric disorders (aOR<!--> <!-->=<!--> <!-->1.66).</div></div><div><h3>Conclusions</h3><div>Given the high morbidity among women identified with PCOS on ICD-10 code E28.2, improved diagnostic algorithms are needed to better identify PCOS cases in health databases and assess their public health implications.</div></div>","PeriodicalId":7917,"journal":{"name":"Annales d'endocrinologie","volume":"87 6","pages":"Article 102598"},"PeriodicalIF":3.4000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales d'endocrinologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003426626001198","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Context
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, but its true burden remains underestimated due to diagnostic variability and underreporting.
Objective
To estimate the morbidities in reproductive-age women identified with a diagnosis of PCOS in the French national health data system.
Methods
We conducted a retrospective cohort study using the French national health data system (SNDS) to identify reproductive-age women (18–43 years) diagnosed with PCOS (ICD-10 code E28.2) between 2014 and 2022. Morbidity data were assessed in 2022 and compared with an age-matched control group of women without PCOS in the same year. Specific comorbidities were identified using a set of algorithms applied to the system's data and based on both ICD-10 codes and medical acts and drug use. Logistic regression models were used to compare comorbidity rates, with odds ratios adjusted for age and social deprivation.
Results
We identified 21,144 women with PCOS in the health data system. Median age was 35 years [IQR: 29–39]. Compared with the general female population, women with PCOS had significantly higher rates of infertility (adjusted odds ratio (aOR) = 24.35), gestational diabetes (aOR = 1.64), type 2 diabetes (aOR 14.71), pulmonary embolism (aOR = 2.04), arterial hypertension (aOR 5.86), acute stroke (aOR= 2.39), cardioneurovascular disease (aOR 2.12) and psychiatric disorders (aOR = 1.66).
Conclusions
Given the high morbidity among women identified with PCOS on ICD-10 code E28.2, improved diagnostic algorithms are needed to better identify PCOS cases in health databases and assess their public health implications.
期刊介绍:
The Annales d''Endocrinologie, mouthpiece of the French Society of Endocrinology (SFE), publishes reviews, articles and case reports coming from clinical, therapeutic and fundamental research in endocrinology and metabolic diseases. Every year, it carries a position paper by a work-group of French-language endocrinologists, on an endocrine pathology chosen by the Society''s Scientific Committee. The journal is also the organ of the Society''s annual Congress, publishing a summary of the symposia, presentations and posters. "Les Must de l''Endocrinologie" is a special booklet brought out for the Congress, with summary articles that are always very well received. And finally, we publish the high-level instructional courses delivered during the Henri-Pierre Klotz International Endocrinology Days. The Annales is a window on the world, keeping alert clinicians up to date on what is going on in diagnosis and treatment in all the areas of our specialty.